Get an email when this journal's indexing changes
Added to or removed from Scopus, Web of Science, ABDC, DOAJ, FT50, UT Dallas or ONOS. One confirmation click; unsubscribe anytime.
npj Genomic Medicine is Scopus-indexed (Q1, CiteScore 7.7), WoS SCIE, DOAJ. Published by Nature Research.
Checked against the index lists dated .
ISSN 2056-7944Verify ISSN ↗
Publisher: Nature Research
Cost to publish: Checking DOAJ for article charges…
| Subject area | Rank | Pctile | Q |
|---|---|---|---|
| Genetics (clinical) | 19 / 100 | 81st | Q1 |
| Genetics | 68 / 357 | 81st | Q1 |
| Molecular Biology | 117 / 414 | 71st | Q2 |
Not listed in: ABDC, ABS / AJG, FT50, UT Dallas, ONOS (subscription), ONOS (APC covered)
Yes — actively indexed in Scopus, coverage 2016–present, best quartile Q1, CiteScore 7.7.
npj Genomic Medicine is Q1 in Genetics (clinical) (rank 19 of 100), Q1 in Genetics (rank 68 of 357) and Q2 in Molecular Biology (rank 117 of 414), by CiteScore 2025.
npj Genomic Medicine is indexed in the Science Citation Index Expanded, so it may have a Journal Impact Factor in Clarivate's Journal Citation Reports. JCR is paid, so check it for the current value. The closest free measure is its Scopus CiteScore 7.7, which places it in quartile Q1 at the 81st percentile of its subject. Its SCImago Journal Rank (SJR, a free Scopus-based metric) is 2.273, quartile Q1, with an H-index of 50.
The publisher lists an article processing charge of about US$4,190 for open access (source: OpenAlex). Many journals also publish by the subscription route at no cost to the author, so confirm on the journal's own website.
npj Genomic Medicine is published by Nature Research. Its ISSN is 2056-7944.
Yes — indexed in the Science Citation Index Expanded.
Yes — it is an open-access journal, listed in DOAJ.
npj Genomic Medicine has an h-index of 63 and a 2-year mean of 5.44 citations per paper (OpenAlex). Its Scopus CiteScore is 7.7, quartile Q1. On 2-year citations it ranks #9 of 99 Scopus journals in Genetics (clinical).
npj Genomic Medicine published 87 papers in 2025; its busiest recent year was 2021 with 107. 2026* is the year so far.
h-index, i10-index and 2-year mean citedness are open, licence-clear metrics from OpenAlex — not a proprietary impact factor. The subject rank counts only journals that OpenAlex has a figure for; it is not a Scopus or Clarivate ranking. Updated 2026-10-14.
In its latest 100 research articles (2025–2026), authors are most often from United States (25.1%), Canada (8.4%) and China (7.2%).
Countries are counted fractionally, so a paper by authors from two countries counts half to each.
Scopus status: Active. No retracted papers are recorded. The Problematic Paper Screener flags none of its papers. These are indicators to check, not findings against the journal.
Retractions from OpenAlex; flags from the Problematic Paper Screener (Cabanac, Labbé & Magazinov, CC BY), 2026-09-21 export. A flag marks a paper for a closer look; it is not a finding against the journal.
Index data is curated from public sources (Scopus, Web of Science, ABDC, FT50, UT Dallas, DOAJ). CiteScore and quartiles reflect the latest available Scopus release. Always verify a journal's current status on its official source before submitting.
Comments load as you scroll here.